How to Buy Mass Tort Leads: A Step-by-Step Guide

Buying mass tort leads involves choosing the right format, verifying screening depth, and applying thorough eligibility review before purchasing significant volume.

Following a structured process helps firms avoid the common pitfalls of purchasing poorly screened or non-viable volume.

Step One: Choosing the Right Format

Real-time exclusive leads, shared leads, and live transfers each suit different intake styles, making format selection the first genuine decision point.

Step Two: Verifying Screening Depth

Confirming a provider's specific screening practices before purchasing protects firms from wasted spend on genuinely non-viable claims.

What Drives Mass Tort Lead Pricing

Price scales with how far a claim has already been pre-qualified. A raw intake lead that only confirms interest in a topic costs far less than a lead that has already confirmed a specific diagnosis date, documented exposure history, and supporting medical records. Litigation stage matters too: leads for an actively filing MDL with a large plaintiff pool typically cost more than an early-stage tort with uncertain case value.

Qualification Criteria That Separate Viable From Non-Viable Claims

The strongest mass tort leads confirm diagnosis or injury date, duration and nature of product exposure, and whether the statute of limitations in the claimant's state has already run. Leads that only capture a name and a vague symptom checklist require far more intake staff time and convert to signed retainers at a much lower rate.

Key Steps to Buying Effectively

• Choosing a format matching your intake capacity.
• Verifying provider screening and compliance practices.
• Testing a smaller batch before scaling.
• Applying careful, individualized eligibility review.

Step Three: Testing With a Smaller Batch

Testing a smaller batch before committing significant budget helps firms validate a specific provider's genuine quality with real experience.

Step Four: Applying Careful Eligibility Review

Given how mass tort eligibility often hinges on specific factual details, thorough individual screening remains essential regardless of a lead's purchase price.

Red Flags When Evaluating a Mass Tort Lead Provider

• The same lead sold to multiple firms without disclosure of shared status.
• No diagnosis date or exposure timeline captured at intake.
• Generic symptom-based screening with no product-specific detail.
• Reluctance to explain their advertising or intake call script.

How to Evaluate a Provider's Screening Process

Ask to review the actual intake script or web form used to generate the lead. A provider that can walk through exactly which questions establish diagnosis timing, exposure duration, and documentation availability is far more credible than one offering only a broad description of their process.

Purchasing Through a Trusted Marketplace

Firms can buy mass tort leads through Eilite's buy leads platform following this same verification process.

Calculating Cost Per Qualified Case

Because mass tort case values vary so widely, cost per qualified case is a more meaningful metric than cost per lead. A pre-qualified lead priced at $150 that converts to a signed retainer 20% of the time costs $750 per case; a $40 unscreened lead converting at 3% costs over $1,300 per case despite the lower sticker price.

How Mass Tort Leads Are Typically Delivered

Leads generally arrive as a real-time web form submission routed directly into an intake CRM, or as a live phone transfer once a call center has completed initial screening. Firms handling high volume should confirm a provider can deliver through an API or standard integration rather than manual spreadsheet exports, which slow down time-sensitive follow-up.

Staffing Intake for Time-Sensitive Volume

Mass tort claimants often submit inquiries to several firms at once, so intake speed genuinely affects signed-case rate. Firms buying meaningful lead volume should ensure intake staff can review and contact a new lead within minutes during business hours, not simply batch-process submissions once or twice a day.

Structuring Contracts for Ongoing Volume

For firms planning to buy mass tort leads on an ongoing basis, negotiating a written agreement covering per-lead pricing, replacement terms for clearly non-viable submissions, and minimum or maximum weekly volume protects both sides and avoids disputes once meaningful budget is committed to a single provider relationship.

Measuring Purchase Performance

Tracking cost per qualified case after each purchase helps firms refine which specific format and provider deliver the strongest results.

Firms who diversify across a small number of vetted sources tend to maintain more consistent intake volume than those depending on one provider.